
Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.78 | 6.68380462725 | 11.67 | 12.2 | 10.5 | 2728 | 11.28975901 | CS |
4 | 1 | 8.73362445415 | 11.45 | 12.25 | 10.31 | 6460 | 11.33781313 | CS |
12 | -2.8097 | -18.4125507055 | 15.2597 | 18.17 | 9.5 | 29064 | 12.8564798 | CS |
26 | 3.55 | 39.8876404494 | 8.9 | 18.17 | 8.1 | 31034 | 11.53939279 | CS |
52 | -1.95 | -13.5416666667 | 14.4 | 18.17 | 5.9999 | 21667 | 11.01027809 | CS |
156 | -32.55 | -72.3333333333 | 45 | 55.95 | 4.5 | 141097 | 11.14241761 | CS |
260 | -130.8 | -91.3089005236 | 143.25 | 210 | 4.5 | 142019 | 30.4369383 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.